2011

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • Milagen is pleased to receive from the Mexico Regulatory Agency COFEPRIS the approval for the commercialization in Mexico to the public and private diagnostic sector, of the following Milagen IVD products of Class I, with validity until 2016:
  • CD34 Registration # 1630R2011SSA
  •  c-ErB2 Registration # 1735R2011SSA
  •  PR Registration # 1754R2011SSA
  •  NSE Registration # 1755R2013SSA
  •  PAP Registration # 1798R2013SSA 
  • PSA Registration # 2108R2013SSA
  •  MUC-5AC Registration #2391R2013SSA
  •  P63 Registration #2496R2013SSA
  • Milagen enters into a partnership with Grupo Columbia for the commercialization of its IVD products in Mexico